Table 4.
Characteristics | Total | N PY | Death | N IDR | |
---|---|---|---|---|---|
Age | ≤1 | 18 (6.3) | 75.66 | 1 | 1.32 |
1-5 | 78 (27.5) | 426.33 | 10 | 2.34 | |
6-10 | 136 (47.9) | 590.58 | 20 | 3.38 | |
11-15 | 52 (18.3) | 164.58 | 4 | 2.43 | |
Mother HIV status | Positive | 219 (77.1) | 1028.08 | 32 | 3.11 |
Negative/unknown | 65 (22.9) | 229.08 | 3 | 1.3 | |
Baseline WHO stage | I & II | 60 (21.1) | 212 | 4 | 1.88 |
III & IV | 224 (78.9) | 1045.166 | 31 | 2.96 | |
Baseline OI | Yes | 261 (91.9) | 1200 | 32 | 2.67 |
No | 23 (8.1) | 57.16 | 3 | 5.24 | |
Baseline HIV related immune suppression | Non-significant/mild | 172 (65.9) | 800.167 | 8 | 9.99 |
Advanced | 46 (16.1) | 196.75 | 6 | 3.04 | |
Sever | 66 (18.1) | 260.25 | 21 | 8.06 | |
Hemoglobin level | ≤10 | 104 (36.6) | 455.91 | 27 | 5.92 |
> 10 | 180 (63.4) | 801.2 | 8 | 0.99 | |
Treatment Failure | Yes | 40 (14.1) | 222 | 3 | 1.35 |
No | 244 (85.9) | 1035 | 32 | 3.09 | |
IPT | Yes | 182 (64.1) | 874 | 19 | 2.17 |
No | 102 (35.9) | 383.16 | 16 | 4.17 | |
CPT | Yes | 260 (91.5) | 11.83 | 33 | 2.8 |
No | 24 (8.5) | 81.3375 | 2 | 2.45 | |
Adherence | Good | 266 (93.7) | 1193.33 | 28 | 2.36 |
Fair/poor | 18 (6.4) | 63.83 | 7 | 10.96 | |
Site of TB | Pulmonary | 218 (76.8) | 1153.66 | 25 | 2.16 |
Extrapulmonary | 66 (23.2) | 103.5 | 10 | 9.66 | |
TB drug Resistance | No | 264 (93) | 1193.33 | 27 | 2.26 |
MDR | 20 (7) | 63.83 | 8 | 12.53 |
PY person year, IDR incidence density rate.